Nanobiotix Files Routine 6-K Report
Ticker: NBTX · Form: 6-K · Filed: May 21, 2025 · CIK: 1760854
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
Nanobiotix filed a standard 6-K, no major news here.
AI Summary
Nanobiotix S.A. filed a Form 6-K on May 21, 2025, to report its activities for the month of May 2025. The company, based in Paris, France, is a foreign private issuer and files its annual reports under Form 20-F. This filing does not appear to contain specific financial updates or material events beyond its routine reporting status.
Why It Matters
This filing indicates Nanobiotix S.A. is fulfilling its regular reporting obligations as a foreign private issuer with the SEC. Investors should look for more specific disclosures for material updates.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain new material information or financial results.
Key Players & Entities
- Nanobiotix S.A. (company) — Registrant
- 001-39777 (company) — SEC File Number
- 20250521 (date) — Filing Date
- 60 Rue de Wattignies, 75012 Paris, France (company) — Principal Executive Office
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of May 2025.
What is Nanobiotix S.A.'s SEC file number?
Nanobiotix S.A.'s SEC file number is 001-39777.
Where is Nanobiotix S.A. located?
Nanobiotix S.A.'s principal executive office is located at 60 Rue de Wattignies, 75012 Paris, France.
Does Nanobiotix S.A. file annual reports under Form 20-F or 40-F?
Nanobiotix S.A. files its annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed on May 21, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 21, 2025 regarding Nanobiotix S.A. (NBTX).